Monday, December 22, 2025

Latest:

Scientists uncover nuclear droplets that link multiple leukemias, a potential new therapeutic target
Should you carbo load before a marathon?
Coping with the pressure to overeat during the holidays: A bariatric perspective
Jingle all the way to an allergy-free holiday
From symptoms to solutions: How new guidelines are changing UTI care in spinal cord injury patients

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Search Results for: prostate cancer

From The Labs

Identical twins share more than identical genes

March 13, 2018 cancer risk, epigenetics, identical twins, Research, supersimilarity

For decades, researchers have studied genetically identical twins to estimate what proportion of disease risk is determined by one’s genes. This approach should be reevaluated,

From The Labs

A new mechanism to explain benign prostatic hyperplasia

October 14, 2016 androgen-targeting therapy, bening prostatic hyperplasia, Il-1, inflammation, prostate

Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, affects about half the men between 51 and 60 years of age, and nine out

From The Labs

New class of small molecule, SI-2, can drug the ‘undruggable’ steroid receptor coactivator-3

June 16, 2016 Cancer, drugs, SI-2, SRC-3, steroid receptor, steroid receptor coactivator

By Ana María Rodríguez, Ph.D. Steroid receptor coactivator-3, which is well-known for its role in cancer formation and proliferation, is usually considered ‘undruggable’ because this nuclear

From The Labs

High throughput microscopy zeroes in on new estrogen receptor regulator

March 3, 2014 Cancer, Microscopy

A high throughput microscopy technique enabled Baylor College of Medicine researchers to identify a new modulator of estrogen receptor alpha that they called UBR5. It